Search research articles
Contact Us
Filters
Showing results (171-180 of 583) with videos related to
Page
of 59
Sort By:
Pediatrics
|
January 1, 1991
Pediatric emergency room visits: a risk factor for acquiring measles
K M Farizo, P A Stehr-Green, D M Simpson, et al.
Vaccine
|
June 12, 2018
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States
Harrell W Chesson, Elissa Meites, Donatus U Ekwueme, et al.
Genetics
|
March 11, 2020
Topoisomerases Modulate the Timing of Meiotic DNA Breakage and Chromosome Morphogenesis in <i>Saccharomyces cerevisiae</i>
Jonna Heldrich, Xiaoji Sun, Luis A Vale-Silva, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
February 8, 2000
A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis
E H Koumans, L E Markowitz, S M Berman, et al.
Journal of Clinical Gastroenterology
|
January 6, 2006
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease
Douglas A Jacobstein, Petar Mamula, Jonathan E Markowitz, et al.
Sexually Transmitted Diseases
|
December 25, 2007
Assessing neonatal herpes reporting in the United States, 2000-2005
Thu-Ha Dinh, Eileen F Dunne, Lauri E Markowitz, et al.
The Journal of Infectious Diseases
|
September 2, 2009
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004
Lauri E Markowitz, Maya Sternberg, Eileen F Dunne, et al.
Sexually Transmitted Diseases
|
January 16, 2007
Contact-tracing outcomes among male syphilis patients in Fulton County, Georgia, 2003
Erika Samoff, Emilia H Koumans, Steven Katkowsky, et al.
Human Vaccines & Immunotherapeutics
|
May 21, 2019
Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States
Harrell W Chesson, Elissa Meites, Donatus U Ekwueme, et al.
Annals of Internal Medicine
|
November 17, 2025
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States
Jean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Page
of 59
Search research articles
Search
Showing results (171-180 of 583) with videos related to
Sort By:
Page
of 59
Pediatrics
|
January 1, 1991
Pediatric emergency room visits: a risk factor for acquiring measles
K M Farizo, P A Stehr-Green, D M Simpson, et al.
Vaccine
|
June 12, 2018
Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States
Harrell W Chesson, Elissa Meites, Donatus U Ekwueme, et al.
Genetics
|
March 11, 2020
Topoisomerases Modulate the Timing of Meiotic DNA Breakage and Chromosome Morphogenesis in <i>Saccharomyces cerevisiae</i>
Jonna Heldrich, Xiaoji Sun, Luis A Vale-Silva, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics
|
February 8, 2000
A public health approach to adverse outcomes of pregnancy associated with bacterial vaginosis
E H Koumans, L E Markowitz, S M Berman, et al.
Journal of Clinical Gastroenterology
|
January 6, 2006
Predictors of immunomodulator use as early therapy in pediatric Crohn's disease
Douglas A Jacobstein, Petar Mamula, Jonathan E Markowitz, et al.
Sexually Transmitted Diseases
|
December 25, 2007
Assessing neonatal herpes reporting in the United States, 2000-2005
Thu-Ha Dinh, Eileen F Dunne, Lauri E Markowitz, et al.
The Journal of Infectious Diseases
|
September 2, 2009
Seroprevalence of human papillomavirus types 6, 11, 16, and 18 in the United States: National Health and Nutrition Examination Survey 2003-2004
Lauri E Markowitz, Maya Sternberg, Eileen F Dunne, et al.
Sexually Transmitted Diseases
|
January 16, 2007
Contact-tracing outcomes among male syphilis patients in Fulton County, Georgia, 2003
Erika Samoff, Emilia H Koumans, Steven Katkowsky, et al.
Human Vaccines & Immunotherapeutics
|
May 21, 2019
Updated medical care cost estimates for HPV-associated cancers: implications for cost-effectiveness analyses of HPV vaccination in the United States
Harrell W Chesson, Elissa Meites, Donatus U Ekwueme, et al.
Annals of Internal Medicine
|
November 17, 2025
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the United States
Jean-François Laprise, Harrell W Chesson, Lauri E Markowitz, et al.
Page
of 59